Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Spontaneous errors in the earliest phase of cell division may explain why so many human embryos fail to develop normally, according to research from Columbia University.
A Mailman study of more than 1 million pregnancies in Finland reports that prenatal exposure to elevated levels of DDT is associated with an increased risk for autism.
Letters written to frequent prescribers of Seroquel, which can cause harmful side effects in the elderly, significantly reduced the number of prescriptions for Medicare patients.
A new way to conduct health studies by tapping the troves of data held in electronic health records may speed medical research and reduce the frequency of conflicting findings.
A new clinical trial suggests that donepezil does not improve cognitive performance in people with mild cognitive impairment who also have clinical depression.
A new National Academies report—co-authored by Columbia Nursing’s Suzanne Bakken—recommends returning health information gathered during research to study participants.
Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2018 Gerstner Scholars and a fifth has been named a Gerstner Merit Awardee.